Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Short-term Investments (2017 - 2022)

Historic Short-term Investments for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $43.8 million.

  • Iterum Therapeutics' Short-term Investments fell 1185.43% to $43.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $43.8 million, marking a year-over-year decrease of 1185.43%. This contributed to the annual value of $53.9 million for FY2021, which is 8973000.0% up from last year.
  • Latest data reveals that Iterum Therapeutics reported Short-term Investments of $43.8 million as of Q3 2022, which was down 1185.43% from $59.7 million recorded in Q2 2022.
  • In the past 5 years, Iterum Therapeutics' Short-term Investments registered a high of $68.5 million during Q3 2018, and its lowest value of $30000.0 during Q2 2019.
  • For the 5-year period, Iterum Therapeutics' Short-term Investments averaged around $28.0 million, with its median value being $36.9 million (2018).
  • Per our database at Business Quant, Iterum Therapeutics' Short-term Investments crashed by 9995.62% in 2019 and then soared by 11279333.33% in 2021.
  • Iterum Therapeutics' Short-term Investments (Quarter) stood at $40.0 million in 2018, then plummeted by 99.92% to $30000.0 in 2019, then surged by 100.0% to $60000.0 in 2020, then soared by 89730.0% to $53.9 million in 2021, then decreased by 18.67% to $43.8 million in 2022.
  • Its Short-term Investments was $43.8 million in Q3 2022, compared to $59.7 million in Q2 2022 and $43.9 million in Q1 2022.